GKSL.NS

SellPremium Grower

Gujarat Kidney And Super Speciality Limited · Healthcare · India · $140M · Avg Vol: $4M/d

Premium Grower: Strong business with the market behind it, priced at a premium.

33
StockRank
Get score and insider alerts
Quality
52
Value
18
Momentum
52

Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →

P/E (TTM)
96.7x
peers 42.9x
ROE
6.1%
peers 11.9%
D/E
0.1x
peers 0.2x
Dividend %
—
trailing yield
Director trades · 180d
None →
Buybacks · 180d
None →

ABOUT GUJARAT KIDNEY AND SUPER SPECIALITY LIMITED

Read

Gujarat Kidney and Super Speciality Limited operates multi-specialty and super-specialty hospitals in India. It provides treatment for Oncology, Neurology, Gastroenterology, Urology, Nephrology, and Physiotherapy.

FINANCIAL SUMMARY (INR)

Year2023202420252026CAGRTTM
Revenue857.9M1.0B367.8M606.0M-10.9%1.0B
EPS (INR)0.841.231.192.4943.6%2.01
Shares78.8M78.8M78.8M78.8M-0.0%78.8M
Debt232.0M273.4M83.1M291.1M7.9%291.0M
Equity219.6M222.7M259.4M2.5B125.7%—
Op CF1.0K12.1M136.1M-38.6M36789.0%-39.1M
Inv CF02.2M-181.4M-2.1B——
Fin CF0-4.7M61.6M2.3B——
Loading 1Y...
PRICE (1Y) · INR+24.2%
15216317318419420 Aug10 Sep1 Oct
SMA 50SMA 200

Close
INR 194.27
RSI (14)
66.4

SCORE BREAKDOWN

Quality
52
ROIC
8.5%66.3
ROE
6.1%58.3
GP/Assets
23.9%52.5
Op. Margin
20.2%83.9
FCF/Assets
-33.0%12.0
Piotroski
430.9
Int. Cover
12.6x65.9
D/E Ratio
0.11x60.8
Current Ratio
3.76x63.9
Value
18
P/E (TTM)
96.7x9.4
EV/EBITDA
58.0x9.4
P/FCF
—N/A
P/B
4.8x27.9
P/S
15.2x18.7
Div Yield
—N/A
Momentum
52
52W High %
—N/A
RS 6M
86%95.5
SMA 50/200
—N/A
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
7%44.8

FUNDAMENTALS

Market Cap
$140M
P/E (Forward)
—
Gross Margin
71.4%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of GKSL.NS are excluded.

TickerCompanyMkt CapStockRankSignal
GKSL.NSGujarat Kidney And Super Speciality Limited(you)$140M33Sell
MAXIND.NSMax India Limited$88M33Sell
SHALBY.NSShalby Limited$161M41Hold
GAUDIUMIVF.NSGaudium IVF and Women Health Limited$88M40Hold
KMCSHIL.NSKMC Speciality Hospitals (India) Limited$268M48Hold
KOVAI.NSKovai Medical Center and Hospital Limited$696M47Hold
JLHL.NSJupiter Life Line Hospitals Limited$915M51Hold
NEPHROPLUS.NSNephrocare Health Services Limited$744M55Hold
GPTHEALTH.NSGPT Healthcare Limited$138M93Strong Buy
HCG.NSHealthCare Global Enterprises Limited$1.1B57Hold

Peer medians: ROE 11.9% · P/E 42.9x · Gross margin 59.4%

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

Gujarat Kidney And Super Speciality Limited (GKSL.NS): Stock Score Summary

Gujarat Kidney And Super Speciality Limited (GKSL.NS) has a MoatMap StockRank of 33/100 based on Quality (52/100), Value (18/100), and Momentum (52/100) factor scores. The current signal is SELL.

Gujarat Kidney and Super Speciality Limited operates multi-specialty and super-specialty hospitals in India. It provides treatment for Oncology, Neurology, Gastroenterology, Urology, Nephrology, and Physiotherapy.

Key Financial Metrics

PriceINR 194.27
Market Cap$140M
P/E (TTM)96.65
Price/Book4.79
Return on Equity6.1%
Return on Invested Capital8.5%
Debt/Equity0.11x
Gross Margin71.4%
Operating Margin20.2%
Revenue Growth124.7%
Free Cash Flow$-10M

Gujarat Kidney And Super Speciality Limited operates in the Medical Care Facilities industry, part of the Healthcare sector (India).

Frequently Asked Questions

What is Gujarat Kidney And Super Speciality Limited’s (GKSL.NS) StockRank?
MoatMap’s StockRank for Gujarat Kidney And Super Speciality Limited (GKSL.NS) is 33/100, with a Sell signal. It is a composite of Quality (52), Value (18), and Momentum (52) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does Gujarat Kidney And Super Speciality Limited have an economic moat?
Gujarat Kidney And Super Speciality Limited (GKSL.NS) has a Quality factor score of 52/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Gujarat Kidney And Super Speciality Limited a buy, hold, or sell?
MoatMap’s current signal for Gujarat Kidney And Super Speciality Limited (GKSL.NS) is Sell, based on a StockRank of 33/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Gujarat Kidney And Super Speciality Limited in?
Gujarat Kidney And Super Speciality Limited (GKSL.NS) operates in the Healthcare sector, specifically the Medical Care Facilities industry (India).
Browse all ranked stocksGKSL.NS deep dive reportAI ChampionsHow we score stocksCheck another stock